Pheophorbide A and Paclitaxel Bioresponsive Nanoparticles as Double-Punch Platform for Cancer Therapy

Cancer therapy is still a challenging issue. To address this, the combination of anticancer drugs with other therapeutic modalities, such as light-triggered therapies, has emerged as a promising approach, primarily when both active ingredients are provided within a single nanosystem. Herein, we desc...

Descripción completa

Detalles Bibliográficos
Autores principales: Moret, Francesca, Menilli, Luca, Battan, Manuele, Tedesco, Daniele, Columbaro, Marta, Guerrini, Andrea, Avancini, Greta, Ferroni, Claudia, Varchi, Greta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399365/
https://www.ncbi.nlm.nih.gov/pubmed/34452091
http://dx.doi.org/10.3390/pharmaceutics13081130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399365/
https://www.ncbi.nlm.nih.gov/pubmed/34452091
http://dx.doi.org/10.3390/pharmaceutics13081130

Ejemplares similares